相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease
Ileana Carrillo et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses
Ting Cai et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Relationship between microvascular changes, autonomic denervation, and myocardial fibrosis in Chagas cardiomyopathy: Evaluation by MRI and SPECT imaging
Gustavo Canavaci Barizon et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2020)
Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease
Yves Jackson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Echocardiographic parameters, speckle tracking, and brain natriuretic peptide levels as indicators of progression of indeterminate stage to Chagas Cardiomyopathy
Luis E. Echeverria et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2020)
State-of-the-art in host-derived biomarkers of Chagas disease prognosis and early evaluation of anti-Trypanosoma cruzi treatment response
Nuria Cortes-Serra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy
Denise Mayumi Tanaka et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2019)
Pathology and Pathogenesis of Chagas Heart Disease
Kevin M. Bonney et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14 (2019)
Could angiotensin-modulating drugs be relevant for the treatment of Trypanosoma cruzi infection? A systematic review of preclinical and clinical evidence
Thaiany G. Souza-Silva et al.
PARASITOLOGY (2019)
T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment
Mauricio Llaguno et al.
INFECTION AND IMMUNITY (2019)
Impaired frequencies and function of platelets and tissue remodeling in chronic Chagas disease
Claudia Pengue et al.
PLOS ONE (2019)
Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail
C. Crespillo-Andujar et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis
Clara Crespillo-Andujar et al.
DRUG SAFETY (2018)
Is endothelial microvascular function equally impaired among patients with chronic Chagas and ischemic cardiomyopathy?
Juliana Pereira Borges et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection: A systematic review and meta-analysis of individual participant data
Yanina Sguassero et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Regional Myocardial Perfusion Disturbance in Experimental Chronic Chagas Cardiomyopathy
Luciano Fonseca Lemos de Oliveira et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
Faustino Torrico et al.
LANCET INFECTIOUS DISEASES (2018)
Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease
Edeltraud J. Lenk et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis
Cinara Stein et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease
Gonzalo R. Acevedo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Molecular diagnostics for Chagas disease: up to date and novel methodologies
Julio Alonso-Padilla et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial
Anis Rassi et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2017)
Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology
Charles N. Serhan
MOLECULAR ASPECTS OF MEDICINE (2017)
E-selectin and sICAM-1, biomarkers of endothelial function, predict recurrence of venous thromboembolism
Olga Dzikowska-Diduch et al.
THROMBOSIS RESEARCH (2017)
The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function
Giovane R. Sousa et al.
PLOS ONE (2017)
Experimental and Clinical Treatment of Chagas Disease: A Review
Policarpo Ademar Sales Junior et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials
I. Molina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Chagas Cardiomyopathy Clinical Presentation and Management in the Americas
Catherine Pastorius Benziger et al.
CARDIOLOGY CLINICS (2017)
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy
C. A. Morillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Chagas' Disease
Caryn Bern
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin
Carolina Campos-Estrada et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Israel Molina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Benznidazole prevents endothelial damage in an experimental model of Chagas disease
Alfredo Molina-Berrios et al.
ACTA TROPICA (2013)
Resolution phase lipid mediators of inflammation: agonists of resolution
Charles N. Serhan et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Treatment of Chagas disease with itraconazole: electrocardiographic and parasitological conditions after 20 years of follow-up
Werner Apt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Protection of vascular endothelium by aspirin in a murine model of chronic Chagas' disease
Alfredo Molina-Berrios et al.
PARASITOLOGY RESEARCH (2013)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
An-Wen Chan et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Protective Role of Acetylsalicylic Acid in Experimental Trypanosoma cruzi Infection: Evidence of a 15-epi-Lipoxin A4-Mediated Effect
Alfredo Molina-Berrios et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Analytical Performance of a Multiplex Real-Time PCR Assay Using TaqMan Probes for Quantification of Trypanosoma cruzi Satellite DNA in Blood Samples
Tomas Duffy et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Novel Lipid Mediators Promote Resolution of Acute Inflammation Impact of Aspirin and Statins
Matthew Spite et al.
CIRCULATION RESEARCH (2010)
Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole
Rodrigo Lopez-Munoz et al.
EXPERIMENTAL PARASITOLOGY (2010)
Dilated cardiomyopathy
John Lynn Jefferies et al.
LANCET (2010)
Changes in Myocardial Perfusion Correlate With Deterioration of Left Ventricular Systolic Function in Chronic Chagas' Cardiomyopathy
Flavio C. Hiss et al.
JACC-CARDIOVASCULAR IMAGING (2009)
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy
Fernando A. Botoni et al.
AMERICAN HEART JOURNAL (2007)
Development and validation of a risk score for predicting death in Chagas' heart disease
Anis Rassi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction
AG Schijman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
分享论文
